Previous studies have demonstrated that bergamottin (BG), a component of grapefruit juice, is a mechanism-based inactivator of CYP3A4 and contributes, in part, to the grapefruit juice-drug interaction. 
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Introduction
Adverse drug-drug interactions involving grapefruit juice were reported more than a decade ago. Grapefruit juice increases the oral availability of a variety of clinically used drugs which are metabolized primarily by CYP3A4 (Ducharme et al., 1995; Kupferschmidt et al., 1995; Benton et al., 1996; Bailey et al., 1998 Bailey et al., , 2000 . Bergamottin (BG) and 6',7'-dihydroxybergamottin (DHBG), the two most abundant furanocoumarins present in grapefruit, have been characterized as reversible inhibitors as well as mechanism-based inactivators of CYP3A4 (Schmiedlin-Ren et al., 1997; He et al., 1998; Guo et al., 2000; Ohnishi et al., 2000; Tassaneeyakul et al., 2000) . Subsequently, studies in primary cultured hepatocytes and more clinically related research with BG and DHBG were pursued (Wen et al., 2002; Kakar et al., 2004; Paine et al., 2004 Paine et al., , 2006 Goosen et al., 2004) . Accelerated degradation of CYP3A4 following covalent modification of the apoprotein by BG and DHBG was confirmed to play a role in the grapefruit juice effect by several in vivo studies (Goosen et al., 2004; Kakar et al., 2004; Paine et al., 2006) .
We have previously demonstrated the covalent binding of a reactive intermediate of [
14 C]BG to the CYP3A4 apoprotein by SDS-polyacrylamide gel electrophoresis (PAGE) (Lin et al., 2005) . However, in those studies, the mass increase of the adducted apo-3A4 and the mass of the reactive intermediate species were not characterized. In the present study, CYP3A4 was reconstituted with NADPH-cytochrome P450 reductase (reductase) and cytochrome b 5 and then inactivated by [ 14 C]BG as previously described (He et al., 1998; Lin et al., 2005) . The [ 14 C]BG labeled apo-3A4 was separated from the reductase by SDS-PAGE and recovered by electroblotting to a nitrocellulose (NC) This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on February 16, 2012 as DOI: 10.1124 at ASPET Journals on July 7, 2017 dmd.aspetjournals.org Downloaded from membrane or to a polyvinylidene difluoride (PVDF) membrane for digestion by lysyl endopeptidase (Lys C) or cyanogen bromide (CNBr), respectively (Roberts et al., 1993) .
All of the peptides that eluted from the PVDF membrane or the NC membrane were further separated by Tricine-SDS-PAGE and subjected to autoradiography (Roberts et al., 1993) . These methods provided information about the stability of the BG-inactivated apoprotein to enzymatic digestion and the approximate size of BG-inactivated peptides.
Oxidation of the double bond of the furan ring to give the furanoepoxide or γ-ketoenal intermediate resulting in modification of P450s has been well documented during the irreversible inactivation of the rat liver microsomal P450s CYP2A6 and CYP2B1 by several furanocoumarins as well as the inactivation of CYP3A4 by furanopyridine (Mays et al., 1989; Sahali-Sahly et al., 1996; Koenigs and Trager 1998a, 1998b; Lightning et al., 2000) . These findings have led us to hypothesize that BG and DHBG, which both contain the intact furanocoumarin core structure, are activated via a similar mechanism to form a reactive intermediate capable of covalently binding with glutathione (GSH) or with amino acid residues in the 3A4 apoprotein (Lin et al., 2005; Kent et al., 2006) .
To unambigiously identify the amino acid residue in CYP3A4 that is covalently adducted by BG using liquid chromatography-tandem mass spectrometry (LC-MS/MS) DMD #44560 7 GSH, only one of the reactive intermediate species covalently binds to the apoprotein of P450 leading to mechanism-based inactivation (Baer et al., 2007; Pearson et al., 2007; Lin et al., 2009) . Thus, it is necessary to determine the mass increase for the apo-3A4 inactivated by the formation of an adduct with BG. Electrospray ionization-liquid chromatography-mass spectrometry (ESI-LC-MS) analysis of an incubation mixture following inactivation revealed two deconvoluted spectra for an unmodified and a modified apo-3A4 that differed in mass by 388 ± 2 Da. The mass increase of 388 Da for the GSH conjugate with MH + at m/z 696 is in good agreement with the mass increase for the formation of an adduct of DHBG plus one oxygen atom with the apoprotein of 3A4 (Bateman et al., 2004) .
This report describes trypsin digestion of BG-inactivated 3A4 followed by LC-MS/MS analysis. The mass shift of 388 Da was used to identify the covalently modified peptide in the tryptic digest by using the SEQUEST database search (Lin et al., 2010) .
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Enzyme Assays and Inactivations. The primary reaction mixture for inactivation contained 60 µg of a mixture of L-α-dilauroyl-phosphocholine, L-α-dioleyl-sn-glycero-3-phosphocholine and L-α-phosphatidylserine (1:1:1), 1 nmol P450, 2 nmol reductase, 1 nmol b 5 , 100 units catalase and 2 mM GSH in a final volumn of 1 ml of 100 mM HEPES buffer (pH 7.4) containing 20% glycerol, 30 mM MgCl 2 , and 0.5 mM EDTA. The reconstituted system was incubated at 37ºC for 30 min and then kept on ice until it was used for the experiments. For the studies on the concentration-and time-dependent inactivation of the P450s by BG, the reactions were initiated by adding 1 mΜ ΝADPH to the primary reaction mixture containing various concentrations of BG at 37ºC. At the time points indicated, 50 μl aliquots were transferred into 950 µl of a secondary reaction mixture containing 100 μM testosterone in 100 mM potassium phosphate buffer (pH 7.7)
with the addition of 200 μM NADPH. Incubations of the secondary reaction mixtures were carried out at 37ºC for 15 min and the reactions were then terminated by the addition of 2 ml of ethyl acetate. The formation of the 6β-hydroxytestosterone product was determined by HPLC analysis as previously described (He et al., 1998 1-2 mm pieces and incubated with 0.5% polyvinylpyrrolidone in 0.5% acetic acid solution for 1 h at 37ºC. The 3A4-containing membrane pieces were rinsed 5 times with water and they were then digested by incubation with 30 mg CNBr in 100 μl of 70% trifluoroacetic acid (TFA) at room temperature for 18 h. The CNBr and TFA were then removed by repeated washing with water and evaporation in a Savant SpeedVac (Thermo Fisher, San Jose, CA) (Roberts et al., 1993) . The peptides generated by treatment with
CNBr were eluted out of the membrane with sample buffer (0.5 M Tris-HCl, 1% SDS, 2% glycerol, 0.02% bromphenol blue, 5% β-mercaptoethanol, pH 6.8) and then analyzed by Tricine-SDS-PAGE (Roberts et al, 1993) .
Digestion of [
14 C]BG-Labeled Apo-3A4 by Lys C on NC Membranes. The same procedure as described above was used for these studies, except that the proteins were transferred to a NC membrane following SDS-PAGE. The 3A4 containing samples were then digested with 2 μg Lys C in 100 μl of 50 mM Tris buffer (pH 8.0) for 18 h at 37ºC.
The resulting peptides were eluted with sample buffer as described above for Tricine-DMD #44560
LC-MS/MS Analysis of GSH Conjugates.
The control (-NADPH) and BG-inactivation samples (+NADPH) containing CYP3A4 or its Q273V mutant were prepared as described above with 50 μM BG for 30 min. After the incubation, samples containing 1 nmol each of P450 were acidified with 60 µl of 10 % TFA and then applied to a 1-ml AccuBond ODS-C18 solid phase extraction cartridge (Agilent Technologies). The cartridges were previously washed with 2 ml of methanol followed by 2 ml of water.
After the samples were loaded, the cartridges were washed with 2 ml of water and the GSH conjugates were then eluted with 2 ml of methanol followed by 0. acetonitrile/0.1% TFA at flow rate 0.2 ml/min in Agilent 1100 series HPLC system (Agilent Techonologies). After 5 min, the column effluent was directed into the mass analyzer of a LCQ mass spectrometer (Thermo Fisher Scientific) as described previously (Lin et al., 2005) . The acetonitrile concentration was increased linearly to 90% over the next 30 min in order to separate the components of the incubation mixture and the mass spectra of the peaks were recorded. The m/z spectra corresponding to the protein envelopes for the CYP3A4 samples were deconvoluted to give the masses associated with each protein envelope using the Bioworks software package (Thermo Fisher Scientific). The ESI source conditions were: sheath gas set at 90 arbitrary units, the auxiliary gas was set at 30 arbitrary units, the spray voltage was 3.5 kV, and the capillary temperature was 200°C.
LC-MS/MS Analysis of the BG-Modified
Residue. The control and BG-inactivated CYP3A4 (500 pmol) were digested with 2 μg trypsin in 100 μl of 50 mM ammonium bicarbonate buffer (pH 8.0) at 37 ºC for 18 h as previously described (Lin et al., 2010) .
The digested peptides were centrifuged at 16,000 x g and the clear supernatant was subjected to analysis using a C18 reversed phase column (Jupiter, 5 μm, 2.0 x 100 mm, Phenomenex initial gradient was 10 to 25% B for 25 min followed by a linear gradient to 65% B over 35 min and then it was increased linearly to 95% B over 10 min at a flow rate of 0.3 ml/min on a Shimadzu LC-10AD system (Kyoto, Japan). The column effluent was directed into a LCQ Deca XP mass spectrometer (Thermo Fisher Scientific). The electrospray ionization conditions were: sheath gas flow rate, 60 arbitrary units; auxiliary gas, 10 arbitrary units; spray voltage, 4.5 kV; capillary voltage, 30 V; capillary temperature 220ºC; and tube lens offset, 60 V. Data were acquired in positive mode using Xcalibur software (Thermo Fisher Scientific) in a data-dependent experiment where MS/MS data were collected on the six most abundant ions in the survey scan.
Metabolism of BG.
WT 3A4 and the Q273V mutant were reconstituted as described above and incubated with 25 μM BG in the presence or absence of NADPH. After incubation for 30 min at 37ºC, the reaction mixtures were extracted with 3 ml of ethyl acetate. The organic phase was dried under N 2 and dissolved in 0.1% acetic acid/50% acetonitrile for high pressure liquid chromatography (HPLC) analysis. The metabolites and BG were separated on a C8 column and monitored at 310 nm according to previous methods (Lin et al., 2005; Kent et al., 2006) . approximately 2.5-3.5 kDa with a minor band at ~4.5 kDa were observed after Lys C cleavage. The results suggested that BG adducted peptides were relatively stable and able to be used for further studies.
LC-MS/MS Analysis of the GSH Conjugates Formed During Metabolism of BG.
The extracted ion chromatograms for the three major GSH conjugates formed during the metabolism of BG by CYP3A4 are shown in Fig Goosen et al., 2004; Kent et al., 2006) .
Mutagenesis Studies of Gln273 to Val in CYP3A4.
The Q273V mutant was constructed, expressed in E. coli, and purified to investigate whether covalent modification of the Gln273 residue was responsible the mechanism-based inactivation of CYP3A4 by BG. The testosterone 6β-hydroxylation activity remaining after incubation of the WT and Q273V mutant of 3A4 with 5−50 μM BG for 5-20 min was determined.
As calculated from the data shown in Fig. 5 , the rate constant for the inactivation is 0.055 min -1 for the WT enzyme incubated with either 5 or 10 μM BG, whereas the rate constant for the Q273V mutant when it is incubated with 50 μM BG is 0.002 min -1 , suggesting that the inactivation of the mutant protein by BG was essentially eliminated by this mutation. The metabolism of BG by the WT and Q273V mutant was also determined by HPLC analysis (Fig. 6 ). As previously reported (Kent et al., 2006) , the WT 3A4 generated four major metabolites (M1, M2, M3 and M5), but the Q273V mutant only generated two major metabolites (M3 and M5). Based on our previous reports on the metabolism of BG by CYP3A5 and CYP2B6, M1 is bergaptol, M2 is DHBG, M3 is 5'-OH-BG and M5 is 2'-OH-BG (Kent et al., 2006) . From the mass increase due to covalent modification of the apoprotein and the mass of the BG-GSH conjugate as described earlier, the reactive intermediate for BG-inactivation appears to be derived from This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Initial studies on the inactivation of CYPs 2B1, 2B4, 2B6, 3A4 and 3A5 using [ 14 C]BG followed by SDS-PAGE separation of the proteins and autoradiography demonstrated that modification of the apoproteins of these P450s contributed to the mechanism-based inactivation (Lin et al., 2005) . Mass spectral analysis of BGinactivated CYPs 2B1, 2B4, 2B6, and 3A5 showed that the mass increases due to the formation of a protein adduct were 380-390 Da, but attempts to elucidate the mass of the BG-modified 3A4 apoprotein were not successful. In the present study, we modified the conditions for the inactivation reaction, the ESI operating parameters, and used a different LC column with a different gradient and were able to observe the 3A4 reported to be ~387 Da (Bateman et al., 2004) . The mass increase for the DHBGinactivated CYP3A5 was determined to be ~392 (Lin et al., 2005 Mutagenesis studies showed that mutation of Gln273 to Val in 3A4 altered the profiles of the products formed during the metabolism of BG with four metabolites formed by the WT 3A4 whereas only two were formed by the Q273V mutant. The formation of bergaptol (M1) is undetectable with the Q273V mutant, suggesting that the modification of the Gln273 may alter the protein conformation such that BG is no longer bound in an orientation that favors cleavage of the geranyl group. DHBG (M2) is formed at extremely low levels by the Q273V mutant, suggesting that not enough of the reactive intermediate is formed under the incubation conditions we used to cause the inactivation.
To test whether the lack of inactivation of Q273V mutant was due primarily to the very slow formation of DHBG or due to the removal of Gln273 preventing formation of the This article has not been copyedited and formatted. The final version may differ from this version. To better understand the structural basis for the effect of Gln273 modification by the reactive intermediate of DHBG on the catalytic activity, we used the known crystal structure of CYP3A4 (PDB ID 1TQN). As shown in Fig. 8A , Gln273 is far away from the heme iron (~20 Å) and not in the active site. However, the hydrogen bonding distance between the amine group of Gln273 and the carboxylate side chain of Asp277 is 2.4 Å (Fig. 8B) . It is reasonable to propose that covalent formation of an amide bond between the NH 2 group of Gln273 and the furanoepoxide of DHBG, as shown in secondary and tertiary structures of CYP3A4, thereby leading to impaired catalysis. It is also interesting to note from this structure that the van der Waals radii of the carbonyl oxygen of Asp277 and the imidazole ring of His267 partially shield Gln273 from complete exposure to the solvent (Fig. 8C ). Therefore, it is possible that the reactive DHBG intermediate may react with the glutamine during its egress from the active site.
In addition, the reactive intermediate may be prevented from coming into contact with GSH in the solvent during its egress from the active site due to shielding by His267 and Asp277.
It is also of interest to note the differences in the positions of adduct formation between the P450 families. For example, the Thr302 residue modified in CYP2B1, CYP2B4, and CYP2B6 by tert-butylphenylacetylene is located in the I-helix and is only ~6 Å away from the heme iron (Zhang et al., 2009; Lin et al., 2010; Zhang et al., 2010; Lin et al., 2011) , whereas the residues of 3A4 modified by BG and raloxifene are all relatively far away from the heme iron. For mechanism-based inactivation of CYP3A4 by raloxifene, Tyr75 (~25 Å away from heme iron) and Cys239 (~21 Å away from heme iron) were identified as the two sites that are covalently modified by the diquinone methide intermediate of raloxifene (Pearson et al., 2007; Yukinaga et al., 2007) . Here, Gln273 is ~20 Å away from heme iron. Perhaps, since the CYP3A4 active site is relatively large and malleable, not only can it accommodate a wide range of structurally diverse substrates but it may also be possible for the reactive intermediate to "tumble'
following its formation and as it exits from the protein active site. Thus, it may not be restrained in the vicinity of the highly conserved Thr in the I-helix where it would be more likely to react due to its proximity.
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